Background
Tuberculosis is a frequent dominant opportunistic infection in HIV-infected individuals and continues to be a leading cause of mortality in this patient population. While pulmonary tuberculosis can often be reliably diagnosed with imaging and sputum analysis, extra-pulmonary disease may often remain obscure. Tuberculosis lymphadenitis is now the most common extra-pulmonary manifestation of tuberculosis in both HIV positive and negative individuals in the USA (Fiske et al. 2010; Heller et al. 2010) Isolated abdominal lymphadenopathy especially presents a diagnostic challenge in HIV-infected patients. The dysfunctional immune response in HIV may obscure signs of infection which may lead to atypical clinical presentations (Bos et al. 2013; Sinkala et al. 2009 ). In endemic areas, Mycobacterium tuberculosis (MTB) accounts for the majority of cases of lymphadenopathy but needs to be differentiated from infections by atypical mycobacteria, other bacterial species, fungi and parasites, conditions such as reactive lymphadenopathy and various malignancies (Giordani et al. 2013; Radin 1995; Sarma et al. 2010) . Imaging studies alone fail to distinguish between different etiologies (Dos Santos et al. 2008) , with the consequence of inaccurate diagnoses and empirical treatment decisions (Mendelson 2007; Navani et al. 2011) . Due to the emergence of multidrug resistant tuberculosis MDR every effort should be made establishing the correct diagnosis and determine drug susceptibilities of the mycobacterium before commencing anti-tuberculosis therapy (Abbadi et al. 2009; WHO 2010) . Various methods have been described to obtain tissue samples from enlarged abdominal lymph nodes that vary in complexity and invasiveness. In general, percutaneous, endoscopic and surgical techniques are available (Gupta and Madoff 2007; Uzunkoy et al.2004; Yasurfuku et al. 2007 ).
Although surgical lymph node biopsy has been considered the gold standard (Bhutani and Logrono 2005) , its invasive nature and related morbidity preclude its general use. Percutaneous-guided biopsies are often not feasible if lesions are in close proximity to major vessels or where there are overlying organs.
Endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) is a minimally invasive procedure that can be performed under conscious sedation, enabling the sampling of different lymph node stations in the mediastinum and abdomen in a single session. EUS-FNA has become an established procedure in obtaining tissue from suspicious gastrointestinal and mediastinal lesions and has a low complication rate (Al-Haddad et al. 2009; Bhutani and Logrono 2005; Saftoiu and Vilmann 2009 ).
The role of endoscopic ultrasound in the assessment of abdominal lymphnodes in HIV infected individuals has not been adequately studied. We hypothesized that in HIV, due to an attenuated dysfunctional immune response, the typical cytological findings associated with mycobacterial disease such as granuloma formation and the presence of acid fast bacilli may be absent or altered.
This study examined the diagnostic efficacy of EUS-FNA in a population of advanced HIV-infected patients and the safety of the procedure in this setting. After obtaining EUS FNA samples the accuracy of various downstream diagnostic modalities were compared and the impact that the results of these investigations had on treatment decisions was examined.
Materials and methods

Study population
A multicenter prospective cohort study was performed and symptomatic HIV-1-infected individuals with abdominal lymphadenopathy were recruited between September 2009 to February 2012 from the HIV Comprehensive Care Clinic and from the Infectious Diseases Units, at Steve Biko Academic and Pretoria East Hospitals, Gauteng, South Africa. These tertiary referral centres specialize in advanced HIV care and therapeutic endoscopy. All symptomatic HIV infected patients seen in follow-up were screened by ultrasonography or computed tomography for the presence of abdominal lymph nodes.
Patients were included in the study if abdominal lymph nodes were larger than 1 cm were present and if a microbiological diagnosis could not be established through standard examination of sputum, fluid, blood or superficial lymph node fine needle aspiration. Patients who were symptomatic despite at least three months of empiric treatment were also included. The most common symptoms observed in such patients were fever, weight loss and night sweats.
A presumptive diagnosis, based on the clinical and radiological information, was formulated by the infectious disease specialist. The endoscopist and pathologist were blinded to this. By comparing the presumptive diagnosis to the final diagnosis the impact of EUS FNA on decision making was examined. Due to the previously described absence of a diagnostic gold standard in such patients, a diagnostic composite was employed that included cytological analysis, culture and PCR. This was done as per the NICE guidelines (Nice Clinical Guidelines 2006) . This protocol followed the principles of the Declaration of Helsinki and was approved by the University of Pretoria Ethics Committee.
Written informed consent was obtained from each participant.
EUS-FNA technique
The procedure was performed under conscious sedation by expert endoscopists (FP, JOJ, SvdM) with more than 10 years experience in echoendoscopy performing more than 500 procedures per year.
Linear array echoscopic ultrasound (Pentax Hitachi 7500) using a standard frequency setting of 7.5Mhz and standard 22-gauge needles (Cook Endoscopy, Limerick, Ireland) were used. The location of lymph nodes (celiac, porta-hepatis, retroperitoneal, para-aortic, mediastinal), number of nodes, echogenicity (hypo-echoic, hyper-echoic, isodense), form (round, matted, elongated), the absence or presence of necrosis were prospectively recorded. In addition tissue elastography was performed and the lymph node classified as hard or soft. FNA was performed by trans-esophageal, gastric or duodenal approach depending on the location of the lymph node groups ( figure 1 a-d) .
The aspirate was characterized as 'bloody' or 'yellow' and smears were prepared and fixed on glass slides for cytological analysis by the gastroenterologist. No pathologist was present in endoscopy suite. Additional aspirates were placed in three sterile tubes containing 500 µL of physiological saline for culture, PCR and flow cytometry. Post-procedure, patients were observed until stable and were monitored telephonically after 24 hours and at day 7 for possible procedure-related complications.
Patients were followed for 3 months following the procedure to correlate endoscopic ultrasound findings with clinical outcome before returning to scheduled clinic visits.
Cytology
Fine needle aspiration material was subjected to Papanicolaou staining (to evaluate morphology), as well as Giemsa, Ziehl-Neelsen (detection of acid fast bacilli [AFB]), periodic acid-Schiff and WarthinStarry stains. The cytological specimens were interpreted by an expert pathologist (TS) blinded to the presumptive diagnosis and endoscopic findings.
PCR technique
DNA was extracted from the aspirate using QIAamp ® DNA Mini kits (Qiagen, Hilden, Germany).
Detection of Mycobacterial DNA was performed using the Roche LightCycler 
Flow cytometry
Fine-needle aspiration specimens were washed twice with RPMI 1640 tissue culture medium, 
Statistics
All data were entered into a Microsoft Excel 2010 spreadsheet and descriptive statistics calculated.
The accuracy of the diagnostic methods was assessed using two approaches. Firstly, due to the high burden of tuberculosis (TB) observed in this study, the ability of the methods to identify TB, and secondly, their ability to identify mycobacterial infections of any kind. That is, the results of the presumptive diagnoses and the individual diagnostic methods were binary classified in terms of their identifying any mycobacteria or TB in particular. In the TB-only analysis, we controlled for those patients undergoing prior anti-tubercular treatment (ATT) or in whom a lymphoma was found to be the final diagnosis. Using Statistix 9 (Analytical software, Tallahassee, Florida, USA) comparisons were made by means of cross tabulation, two-tailed Fischer exact tests and the calculation of positive and negative predictive values, between the results of each of the methods versus the final diagnosis. A p < 0.05 value was considered significant.
Results
EUS-FNA assessment was conducted on 31 HIV-1-infected patients with pathologically enlarged abdominal lymph nodes. All patients had advanced HIV disease. The characteristics and the findings for the patients studied are given in Table 1 , with more detailed individual patient findings given in the supplementary text.
EUS detected enlarged lymph nodes in all patients. Para-aortic and porta-hepatis nodes were the most common locations found in 20 (64,5 %) and 17 (54,8 %) of patients respectively, while 8 (25,8 %) of patients had additional mediastinal nodes. The mean diameter of the nodes were 28mm (15-63mm). The endoscopic ultrasound appearance of lymph nodes was highly variable including evidence of necrosis (inhomogenous with central hypo-echogenicity) (32%), hypoechoic (48%), iso and hyper-echoic appearances (20%) (figure 1 a-d). Tissue elastography was not useful in separating reactive lymph nodes from tuberculous lymphadenitis. Extra-nodal lesions were also found in 7 (22.5 %) of patients including: an infected sub-diaphragmatic multi-loculated cyst (5,6cm x 2,3cm) that was drained, one peri-pancreatic cold abscess and pericardial effusions. Only one pericardial effusion was considered clinically important and was aspirated under EUS guidance where PCR and culture confirmed MTB. The procedure was found to be safe in this patient population and no immediate or post-procedural (48 hours) complications were reported.
Cytology yielded the following results in patients with a final diagnosis of a mycobacterial infection:
AFB were detected in 38%, culture was positive in 67% and PCR in 90%. The mean time to positive culture was 25 days (13-49). Overall MTB was diagnosed in 17/31 (54.8%) patients, MAC in 5/31 (16.1%) and mixed TB/MAC in 1/31 (3%) of patients. In all but two MTB PCR positive patients, there was sufficient target DNA to perform direct drug sensitivity genotyping, leading to two patients being diagnosed with drug resistant tuberculosis. In all cases the final diagnosis was based on a combination of at least 2 of the following: cytology, culture and PCR. In one case, flow cytometry was unable to characterize a lymphoma and a surgical excision biopsy was required for confirmation of the subtype.
The accuracy of the diagnostic methods relative to identifying TB is given in patients. In addition 7/31 (23%) patients were diagnosed with a fungal infection. Fungal species identified included Candida Albicans (57% of 4/7), Candida Glabrata (29% of 2/7) and Candida Krusi (14% of 1/7). Forty three percent (3/7) were PCR and culture positive and 29% (2/7) were culture and cytology positive. Fungal infections were only considered clinically relevant if the sample that yielded the positive result was obtained from the stomach or duodenum. It however remains difficult to differentiate mucosal contaminants from invasive infections, at least to regional lymph nodes in this population.
In general, the main findings of this study were: i. Neither the size nor the EUS appearance could differentiate reactive from pathological lymph nodes ii. The cytological analysis of the aspirate alone had a low diagnostic accuracy even in patients not on anti-tuberculous therapy. iii. PCR had a high diagnostic accuracy in mycobacterial infection allowing a rapid diagnosis and early initiation of therapy. Following the various procedures all patients were placed on treatment according to the final diagnosis and followed up for 3 months by study protocol before returning to scheduled clinic visits. One patient, diagnosed with 4 opportunistic infections, including Cytomegalovirus (CMV), MTB pericarditis, Mycobacterium avium complex (MAC) and C. Glabrata, died during the observational period despite the initiation of appropriate therapy. All other patients stabilized or improved on specific therapy during the observational period.
Discussion
The safety and diagnostic accuracy of endoscopic ultrasound in the assessment of mass lesions and lymphadenopathy in immuno-competent individuals is well established. In HIV-infected individuals the aberrant immune response may affect EUS interpretation of lymph nodes and the diagnostic accuracy of the aspirate. Such patients are predisposed to a multitude of opportunistic infections as well as hematological and other malignancies, frequently with atypical clinical presentations (Sinkala et al. 2009 ). Additionally, cytological findings characteristic of bacterial infection, such as granuloma formation or the presence of acid fast bacilli, may be absent or altered (Mendelson 2007) .
In general, two strategies can be followed when managing HIV/AIDS infected patients with sputum smear negative tuberculosis with abdominal lymphadenopathy. Firstly, patients may be placed on empirical therapy. In MTB endemic settings, anti-tubercular drugs may be initiated however this approach may risk adverse drug reactions and interactions, hepatotoxicity and miss other pathology (Mendelson 2007 ). Indeed, a study from India using EUS FNA to assess abdominal lymphadenopathy in HIV-uninfected patients, confirmed that almost half of the patients in this high endemic region were found to have non-tubercular pathology (Dhir et al. 2011 ) Similarly, our study confirmed that 31% of HIV infected patients with enlarged nodes, even in a high endemic area such as South Africa, had reactive lymphadenopathy. This implies that empirical ATT, prescribed solely on the basis of the presence of enlarged lymph nodes, may be associated with considerable treatment-related risks and should consequently be avoided.
Secondly, a tissue sample may be obtained allowing treatment decisions to be based on a laboratory confirmed diagnosis. Multiple sampling modalities are available including percutaneous FNA and minimally invasive surgery; neither has been extensively investigated in an HIV-positive population.
Percutaneous ultrasound-guided FNA in HIV-positive patients has been reported to have a high technical success rate and diagnostic accuracy but only allows assessment of large, superficial nodes (Veerapand et al 2004) . In patients with overlying organs, where multiple lymph nodes sites are affected, or smaller and deeper nodes, percutaneous sampling becomes challenging (Gupta and Madoff 2007) . In this study we report that endoscopic ultrasound is safe and effective in evaluating abdominal lymphadenopathy and obtaining tissue samples in HIV infected patients.
Classic EUS findings that have been proposed to differentiate between pathological and reactive nodes, include size greater than 1 cm, a round shape, hypo-echoic texture and sharp margins (Catalano et al. 1994) . These findings were common in our study and not useful in differentiating between tuberculous lymphadenitis and reactive lymphadenopathy. Recent studies of mediastinal MTB in HIV-negative patients have found the presence of hypo-echoic nodes in the majority of patients (Song et al. 2010) , and that the lymph node appearance alone could not reliably differentiate tuberculous nodes from nodes due to sarcoidosis (Fritscher-Ravens et al. 2011) . In our study the EUS appearance of lymph nodes in HIV-infected patients was highly variable, including a hypo-echoic texture, particularly when nodes smaller than 2cm were observed. Nodes also demonstrated central breakdown, extensive necrosis and with a matted or hyper-echoic appearance (Figure 1 ).
In HIV-uninfected patients, FNA aspirates obtained by EUS are routinely analyzed by cytology. A large study from India assessing mediastinal lymph nodes by EUS FNA based on cytology only, found an overall diagnostic yield of 93% (Puri et al.2010 ). Navani and coworkers (2011) showed, using endobronchial ultrasound-guided transbronchial needle aspiration, cytological findings consistent with tuberculosis in 86% of cases. Yet culture was only positive in 47% of patients implying that treatment decisions were based mainly on cytological findings without the opportunity to differentiate MTB from MAC or to assess drug resistance. In our study, findings typically associated with mycobacterial disease such as granuloma formation were often absent, most likely due to HIVassociated immunosuppression. We found the presence of necrosis on cytology to be predictive of a positive mycobacterial culture and PCR. Additionally, although highly specific for mycobacterial disease, microscopy in the form of Ziehl-Nielsen staining for acid-fast bacilli (AFB), cannot reliably differentiate between MTB and MAC nor identify drug resistant strains.
Culture has historically been considered the gold standard in identifying and differentiating mycobacterium species but may take up to six weeks and is therefore of little value in early patient management, particularly in immune-compromised patients prone to rapid progression and early mortality (Mendelson 2007 ). In our study mycobacterial culture was positive in only 67% of patients with the mean time to a positive culture of 25 days that would considerably delay initiation of effective therapy. A recent study in patients with isolated mediastinal lymphadenopathy suggests that culture yields may be lower in HIV positive patients (Navani et al. 2011) . In that study in a subgroup of 17 HIV positive patients only 36% had positive mycobacterial cultures. Collectively the published data suggest that FNA subjected to cytology and culture only, is inadequate in obtaining a final diagnosis in the majority of HIV positive patients with abdominal lymphadenopathy. In contrast PCR amplifying mycobacterial DNA had a diagnostic accuracy of 94%. Combining all modalities we could show that the final diagnosis changed from the presumptive diagnosis as formulated by the infectious disease specialist leading to a change in the management in 42% of patients.
Based on the calculated positive and negative predictive values of the various post EUS-FNA modalities we defined a diagnostic algorithm (figure 2). Our results demonstrated that the presence of a yellow aspirate in combination with caseous necrosis on cytology had a PPV of 96% whereas a bloody aspirate in the absence of caseous necrosis had a 77% NPV which can be used to determine in which patients additional PCR should be performed. PCR remains imperative to differentiate MDR-TB strains and MTB from MAC.
Our detailed prospective analysis which assessed the diagnostic accuracy of EUS guided FNA was performed on a relatively small sample size of patients with advanced HIV infection. The results of our study need to be validated in a larger cohort of patients. We also realize that endoscopic Proposed diagnostic algorithm to assess samples obtained from lymph nodes in symptomatic HIV positive patients with abdominal and or mediastinal lymphadenopathy. All patients with lymphadenopathy should be subjected to FNA irrespective of the appearance of the lymph nodes. A "yellow" aspirate in the presence of necrosis on cytology is highly predictive of mycobacterial disease. These samples should be subjected to further analysis with culture and PCR to differentiate MTB from MAC and exclude genotypic resistance. If the aspirate is "bloody" and necrosis is not detected on cytology mycobacterial disease is highly unlikely. Such a sample should be subjected to culture and the patient carefully followed. In event of progression an excision lymph node biopsy should be performed to exclude lymphoma.
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